Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell cycle phase recovery from bleomycin-induced potentially lethal damage.

S C Barranco, W E Bolton

    Cancer Research
    |August 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Strategies for cell permeabilization and fixation in detecting surface and intracellular antigens.

    Methods in cell biology·2000
    Same author

    Cytometry of caspases.

    Methods in cell biology·2000
    Same author

    Intracellular markers.

    Journal of immunological methods·2000
    Same author

    Relationship between colorectal cancer glutathione levels and patient survival: early results.

    Diseases of the colon and rectum·2000
    Same author

    Use of artificial neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer patients.

    The Prostate·1999
    Same author

    Differentiation and assessment of cell death.

    Clinical chemistry and laboratory medicine·1999

    Mammalian cells in mitosis cannot recover from bleomycin damage, while G1 and S phase cells can. A fixed recovery level occurs regardless of initial damage, but the mechanism remains unknown.

    Area of Science:

    • Cell biology
    • Cancer research
    • Drug toxicology

    Background:

    • Anticancer drugs like bleomycin can cause potentially lethal damage to mammalian cells.
    • Cell cycle phase influences cellular response to DNA-damaging agents.
    • Understanding cell recovery mechanisms is crucial for cancer therapy optimization.

    Purpose of the Study:

    • To investigate the differential recovery of mammalian cells from bleomycin-induced damage based on cell cycle phase.
    • To determine if a consistent recovery potential exists irrespective of initial damage levels.

    Main Methods:

    • Utilizing synchronized mammalian cell populations (G1, S, and M phases).
    • Treating cells with the anticancer drug bleomycin at potentially lethal doses.
    • Assessing cell survival rates after treatment and recovery periods.

    Related Experiment Videos

    Main Results:

    • Cells treated during mitosis (M phase) were unable to recover from bleomycin-induced damage.
    • Cells in G1 and S phases demonstrated recovery capabilities.
    • Recovered cells consistently showed survival values greater than 0.2, irrespective of initial damage extent.

    Conclusions:

    • Mitotic phase is a critical window where bleomycin-induced damage is irreparable.
    • A fixed, non-variable recovery capacity exists for bleomycin-damaged cells in G1/S phases.
    • The underlying mechanism for this fixed recovery phenomenon requires further investigation.